-+ 0.00%
-+ 0.00%
-+ 0.00%

Forte Biosciences shareholders approve amended, restated 2021 equity incentive plan at annual meeting

PUBT·06/02/2026 20:02:23
Listen to the news
Forte Biosciences shareholders approve amended, restated 2021 equity incentive plan at annual meeting
  • Forte Biosciences held its annual shareholder meeting on May 29, 2026.
  • Shareholders ratified KPMG as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders authorized an amended and restated 2021 Equity Incentive Plan, expanding the share reserve to 5,190,000 shares, with up to 44,093 additional shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Forte Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-253436), on June 02, 2026, and is solely responsible for the information contained therein.